DHR Danaher Corporation Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

DHR [NYSE]

Danaher Corporation

Healthcare | Diagnostics & Research | USA

statements

Index	S&P 500	P/E	52.25	EPS (ttm)	4.16	Insider Own	0.40%	Shs Outstand	710.90M	Perf Week	-3.33%
Market Cap	154.36B	Forward P/E	30.32	EPS next Y	7.16	Insider Trans	-13.45%	Shs Float	630.29M	Perf Month	-9.41%
Income	2.99B	PEG	3.45	EPS next Q	1.83	Inst Own	81.70%	Short Float	0.95%	Perf Quarter	6.28%
Sales	18.36B	P/S	8.41	EPS this Y	-2.20%	Inst Trans	0.22%	Short Ratio	2.50	Perf Half Y	30.38%
Book/sh	48.80	P/B	4.45	EPS next Y	18.88%	ROA	5.20%	Target Price	263.75	Perf Year	48.80%
Cash/sh	8.00	P/C	27.14	EPS next 5Y	15.14%	ROE	11.30%	52W Range	119.60 - 248.32	Perf YTD	41.53%
Dividend	0.72	P/FCF	39.39	EPS past 5Y	7.60%	ROI	4.70%	52W High	-12.52%	Beta	0.77
Dividend %	0.33%	Quick Ratio	1.70	Sales past 5Y	6.80%	Gross Margin	55.00%	52W Low	81.62%	ATR	6.48
Employees	60000	Current Ratio	2.10	Sales Q/Q	34.40%	Oper. Margin	21.30%	RSI (14)	38.77	Volatility	2.66% 2.86%
Optionable	Yes	Debt/Eq	0.63	EPS Q/Q	38.80%	Profit Margin	19.40%	Rel Volume	1.34	Prev Close	217.22
Shortable	Yes	LT Debt/Eq	0.63	Earnings	Oct 22 BMO	Payout	13.90%	Avg Volume	2.41M	Price	217.22
Recom	1.70	SMA20	-5.67%	SMA50	-3.01%	SMA200	17.70%	Volume	0	Change	0.00%

Nov-25-20

Downgrade

RBC Capital Mkts

Outperform → Sector Perform

$273 → $234

Nov-10-20

Initiated

KeyBanc Capital Markets

Overweight

$280

Jun-16-20

Upgrade

Wolfe Research

Peer Perform → Outperform

Apr-02-20

Downgrade

Wolfe Research

Outperform → Peer Perform

$154

Mar-26-20

Upgrade

RBC Capital Mkts

Sector Perform → Outperform

$151 → $157

Feb-03-20

Reiterated

Needham

Buy

$167 → $187

Jan-08-20

Initiated

Wells Fargo

Overweight

$170

Jan-07-20

Initiated

Citigroup

Buy

$180

Nov-15-19

Resumed

Stifel

Hold

Oct-28-19

Reiterated

Needham

Buy

$155 → $152

Oct-14-19

Resumed

Credit Suisse

Outperform

$151

Jul-19-19

Reiterated

Needham

Buy

$142 → $155

Jun-11-19

Initiated

Piper Jaffray

Neutral

May-30-19

Initiated

Wolfe Research

Outperform

Apr-17-19

Reiterated

Needham

Buy

$138 → $141

Feb-28-19

Reiterated

Needham

Buy

$114 → $138

Feb-25-19

Upgrade

Janney

Neutral → Buy

Jan-03-19

Initiated

Needham

Buy

$114

Apr-20-18

Reiterated

Stifel

Buy

$108 → $114

Feb-15-18

Initiated

Barclays

Overweight

$110

Nov-25-20 03:49PM	RBC Downgrades Danaher, Says Defensive Portfolio 'Less Compelling To Own' Benzinga
Nov-24-20 05:48PM	3M (MMM) Teams with Safran for Aircraft Interior Solution Zacks
05:00PM	Danaher To Present At Evercore ISI HealthCONx Conference PR Newswire
Nov-23-20 09:13AM	Danaher's Debt Overview Benzinga
08:00AM	Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antibody test PR Newswire
Nov-22-20 02:10AM	Here's Why I Think Danaher (NYSE:DHR) Is An Interesting Stock Simply Wall St.
Nov-21-20 11:30AM	Danaher (DHR) Down 3.5% Since Last Earnings Report: Can It Rebound? Zacks
Nov-20-20 07:37AM	Is Danaher Stock a Buy? Motley Fool
Nov-17-20 09:13AM	Crane (CR) to Benefit From Buyouts and Growth Investments Zacks
Nov-16-20 04:15PM	Danaher To Present At Wolfe Research Healthcare Conference PR Newswire
Nov-15-20 09:51PM	Top 10 Stocks Billionaire Ray Dalio Just Bought Insider Monkey
Nov-11-20 01:56PM	5 Reasons Why Danaher (DHR) Stock is Worth Investing in Now Zacks
Nov-10-20 04:15PM	Danaher Releases 2020 Sustainability Report PR Newswire
03:00AM	Beckman Coulter launches its SARS-CoV-2 IgM antibody test in countries accepting CE Mark and will begin shipping to diagnostics labs PR Newswire
Nov-06-20 01:12PM	Analysts Say These 3 Stocks Are Their Top Picks for 2021 TipRanks
Nov-04-20 07:35AM	These 4 Top Stocks Have Surpassed Management's Highest Expectations Motley Fool
Nov-02-20 10:51AM	ITT Q3 Earnings and Revenues Beat Estimates, Decline Y/Y Zacks
Oct-30-20 07:37AM	Danaher Is One of the Big Winners From COVID-19 Motley Fool
Oct-29-20 12:20PM	Surging Earnings Estimates Signal Upside for Danaher (DHR) Stock Zacks
Oct-28-20 12:31PM	3 Tech Growth Stocks to Consider GuruFocus.com
Oct-27-20 08:22AM	Crane (CR) Q3 Earnings & Revenues Surpass Estimates, Down Y/Y Zacks
07:49AM	5 Top Momentum Picks Screened on Driehaus Strategy Zacks
04:00AM	Cytiva strengthens support to diagnostics industry with new labs, services and supply chain enhancements PR Newswire
Oct-26-20 11:51PM	Apple (AAPL), Amazon (AMZN) Among Brasada Capital Managements Biggest Quarterly Moves Insider Monkey
Oct-23-20 09:51AM	Top Ranked Momentum Stocks to Buy for October 23rd Zacks
Oct-22-20 04:24PM	Danaher Earnings Beat With DHR Stock At Record Highs Investor's Business Daily
01:00PM	Danaher Corp (DHR) Q3 2020 Earnings Call Transcript Motley Fool
10:52AM	Danaher (DHR) Q3 Earnings Beat, Rise Y/Y on Sales Growth Zacks
09:14AM	The Zacks Analyst Blog Highlights: Danaher Corp, PulteGroup, Penske Automotive, Mattel and Altra Industrial Motion Corp Zacks
07:30AM	Danaher (DHR) Tops Q3 Earnings and Revenue Estimates Zacks
07:18AM	Recap: Danaher Q3 Earnings Benzinga
06:00AM	Danaher Reports Third Quarter 2020 Results PR Newswire
Oct-21-20 10:12AM	Earnings Preview: Danaher Benzinga
09:48AM	Why Earnings Season Could Be Great for Danaher (DHR) Zacks
09:19AM	Carlisle (CSL) Q3 Earnings Surpass Estimates, Revenues Miss Zacks
07:55AM	5 High-Flying Stocks With Room to Run on Q3 Earnings This Week Zacks
Oct-20-20 12:39PM	Were Hedge Funds Right About Crowding Danaher Corporation (DHR)? Insider Monkey
12:00PM	Danaher (DHR) is a Great Momentum Stock: Should You Buy? Zacks
11:40AM	ITT vs. DHR: Which Stock Is the Better Value Option? Zacks
Oct-19-20 12:58PM	The Zacks Analyst Blog Highlights: PPG, PG, Philip Morris, Northrop and Danaher Zacks
11:07AM	Danaher (DHR) to Report Q3 Earnings: Is a Beat in Store? Zacks
Oct-17-20 10:38AM	When Should You Buy Danaher Corporation (NYSE:DHR)? Simply Wall St.
04:53AM	Moody's Outlook for the US medical products and devices industry revised to positive on higher earnings, increased demand Moody's
Oct-16-20 07:29AM	Buy 5 Corporate Giants Ahead of Earnings Results Next Week Zacks
Oct-15-20 12:32PM	Danaher (DHR) Earnings Expected to Grow: Should You Buy? Zacks
08:00AM	Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C), a severe COVID-19 complication in Children PR Newswire
Oct-14-20 08:36AM	Macquarie (MIC) Displays Bright Prospects, Risks Persist Zacks
Oct-12-20 10:45AM	The Zacks Analyst Blog Highlights: Lennar Corp, Activision Blizzard, Danaher Corp, Installed Building Products and Galiano Gold Zacks
Oct-09-20 08:00AM	Beckman Coulter SARS-CoV-2 IgM Antibody Test Receives FDA Emergency Use Authorization PR Newswire
Oct-07-20 04:15PM	Danaher Schedules Third Quarter 2020 Earnings Conference Call PR Newswire
12:10PM	Why the Earnings Surprise Streak Could Continue for Danaher (DHR) Zacks
10:40AM	Danaher Restructure Debt With Senior Notes Issue & Redemption Zacks
Oct-06-20 08:54AM	3 Top Stocks From the Booming Diversified Operations Industry Zacks
07:00AM	Danaher Announces Redemption Of Senior Notes PR Newswire
Oct-02-20 11:40AM	ITT vs. DHR: Which Stock Should Value Investors Buy Now? Zacks
Sep-30-20 09:41AM	Nike, OrganiGram, Thermo Fisher, Danaher Corp and Agilent Tech highlighted as Zacks Bull and Bear of the Day Zacks
09:06AM	Danaher (DHR) Prices Public Offering of $1B Senior Notes Zacks
Sep-29-20 09:30PM	Danaher Announces Pricing Of Senior Notes Offering PR Newswire
03:09PM	Abbott Gets the First Big Orders for Its Fast Covid Test Barrons.com
09:09AM	Danaher (DHR) Gains 19% in 3 Months: What's Driving It? Zacks
07:00AM	Cepheid Receives Emergency Use Authorization For SARS-CoV-2, Flu A, Flu B and RSV Combination Test PR Newswire
Sep-28-20 11:32AM	Barrons Stock Pick: Fortive Is Spinning Off a Business. Its Time to Buy the Stock. Barrons.com
05:30AM	What Wall Street Is Saying About Industrial Firm Fortives Upcoming Split Barrons.com
Sep-27-20 07:47AM	3 Cheap Stocks to Buy After the Market Sell-Off Motley Fool
Sep-25-20 05:45PM	Correction Notice To Press Release Regarding Dividend Amount PR Newswire
11:15AM	Danaher Corp (DHR) Has Risen 43% in Last One Year, Outperforms Market Insider Monkey
08:38AM	3 Conglomerates to Shine Despite Pandemic-Led Uncertainties Zacks
Sep-18-20 08:58AM	AstraZeneca Stock Showing Improved Relative Strength With RS Line Trending Up Investor's Business Daily
06:09AM	For Investors in Danaher Stock, Breaking Up Should Be Hard to Do Motley Fool
Sep-17-20 07:18PM	'Halftime Report' Traders Share Their Thoughts On Danaher, Uber And IBM Benzinga
09:07AM	Estimating The Fair Value Of Danaher Corporation (NYSE:DHR) Simply Wall St.
Sep-15-20 04:15PM	Danaher Announces Quarterly Dividend PR Newswire
09:00AM	Beckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Detection with the DxH 690T PR Newswire
09:00AM	Beckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Detection with the DxH 690T CNW Group
Sep-13-20 03:00PM	5 years, 500 million USD, and nearly 1,000 people: Cytiva invests for global capacity expansion PR Newswire
03:00PM	5 years, 500 million USD, and nearly 1,000 people: Cytiva invests for global capacity expansion CNW Group
Sep-03-20 08:00AM	Why an Outperforming $3.6B ESG Fund Likes Amazon, Starbucks, and Danaher Stock Barrons.com
Sep-02-20 02:36PM	Buy General Electric at $6.50 Before It Jumps 150% InvestorPlace
Sep-01-20 04:15PM	Danaher Appoints Rainer M. Blair As President And CEO PR Newswire
Aug-28-20 05:50PM	Danaher (DHR) Gains But Lags Market: What You Should Know Zacks
03:05PM	Hedge Funds Cant Stop Buying Danaher Corporation (DHR) Insider Monkey
01:05PM	Abbott Laboratories Meets 80-Plus Relative Strength Rating Benchmark Investor's Business Daily
Aug-27-20 09:40AM	Reasons Why Danaher (DHR) is an Attractive Investment Option Zacks
Aug-25-20 01:59PM	5 Companies Reach 52-Week Highs GuruFocus.com
Aug-24-20 08:00AM	Beckman Coulter Launches SARS-CoV-2 IgM Antibody Test and will begin shipping to U.S. Diagnostics Labs PR Newswire
Aug-22-20 11:30AM	Why Is Danaher (DHR) Up 4.3% Since Last Earnings Report? Zacks
07:45AM	Is Danaher Stock a Buy? Motley Fool
Aug-18-20 11:26AM	The Danaher (NYSE:DHR) Share Price Has Gained 149%, So Why Not Pay It Some Attention? Simply Wall St.
10:35AM	Crane to Benefit From Acquisitions Amid Pandemic Scares Zacks
Aug-14-20 09:13AM	Griffon Prices 8M Underwritten Public Common Share Offering Zacks
Aug-10-20 08:00AM	Ariel Investments' John Rogers Shares Insight About Stocks, Racial Relations Investor's Business Daily
Aug-07-20 12:24PM	5 Health Care Companies Outperforming the Market GuruFocus.com
Aug-02-20 10:53AM	GE Competitor Siemens Healthineers Makes Blockbuster Acquisition Barrons.com
Jul-31-20 12:58PM	Vanguard Health Care Fund Adds 3 Stocks to Portfolio GuruFocus.com
12:25PM	3 Zacks Rank #1s Making New Highs Zacks
Jul-30-20 09:50AM	Should You Buy Danaher Stock at Its All-Time High? Motley Fool
Jul-29-20 12:20PM	Earnings Estimates Rising for Danaher (DHR): Will It Gain? Zacks
Jul-28-20 12:00PM	Here's Why Danaher (DHR) is a Great Momentum Stock to Buy Zacks
Jul-27-20 07:00AM	INSIGHT-The U.S. has more COVID-19 testing than most. So why is it falling so short? Reuters
Jul-23-20 04:06PM	Covid Report: Why These Health Stocks Diverged On Strong Testing Sales Investor's Business Daily

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RALES MITCHELL P	Chairman of Exec. Committee	Nov 19	Buy	226.14	26,784	6,056,934	2,404,658	Nov 23 07:41 PM
Zerhouni Elias A.	Director	Nov 03	Option Exercise	38.39	8,898	341,557	38,109	Nov 04 05:26 PM
Zerhouni Elias A.	Director	Nov 03	Sale	233.71	8,898	2,079,594	33,561	Nov 04 05:26 PM
LUTZ ROBERT S	SVP-Chief Accounting Officer	Oct 23	Option Exercise	46.13	24,594	1,134,521	43,544	Oct 27 05:14 PM
COMAS DANIEL L	EVP	Oct 23	Option Exercise	65.83	54,402	3,581,284	130,161	Oct 27 05:13 PM
Raskas Daniel	SVP-Corporate Development	Oct 23	Option Exercise	40.45	28,389	1,148,335	38,850	Oct 27 05:14 PM
Raskas Daniel	SVP-Corporate Development	Oct 23	Sale	234.50	28,389	6,657,177	19,723	Oct 27 05:14 PM
COMAS DANIEL L	EVP	Oct 23	Sale	233.25	54,402	12,689,037	92,683	Oct 27 05:13 PM
LUTZ ROBERT S	SVP-Chief Accounting Officer	Oct 23	Sale	233.19	24,594	5,735,039	18,950	Oct 27 05:14 PM
Lalor Angela S	SVP, Human Resources	Aug 31	Option Exercise	57.21	38,955	2,228,591	58,330	Sep 01 05:45 PM
Lalor Angela S	SVP, Human Resources	Aug 31	Sale	206.00	38,955	8,024,730	35,910	Sep 01 05:45 PM
Lalor Angela S	SVP, Human Resources	Aug 28	Option Exercise	57.21	38,954	2,228,534	58,329	Sep 01 05:45 PM
Lalor Angela S	SVP, Human Resources	Aug 28	Sale	205.00	38,954	7,985,570	35,910	Sep 01 05:45 PM
McGrew Matthew	EVP & Chief Financial Officer	Jul 29	Sale	203.42	7,457	1,516,925	12,387	Jul 30 07:13 PM
King William	SVP, Strategic Development	Jul 28	Option Exercise	54.31	26,982	1,465,367	40,339	Jul 29 05:11 PM
King William	SVP, Strategic Development	Jul 28	Sale	199.09	26,982	5,371,878	21,589	Jul 29 05:11 PM
LOHR WALTER G	Director	Jul 28	Sale	198.56	57,000	11,317,692	391,000	Jul 29 05:10 PM
HEFNER LINDA P	Director	Jul 27	Option Exercise	28.98	11,014	319,186	38,255	Jul 28 06:13 PM
Zerhouni Elias A.	Director	Jul 27	Option Exercise	28.98	11,014	319,186	34,809	Jul 28 06:17 PM
Weidemanis Joakim	Executive Vice President	Jul 27	Option Exercise	36.87	19,834	731,280	112,548	Jul 28 06:16 PM
HEFNER LINDA P	Director	Jul 27	Sale	197.00	2,754	542,538	29,995	Jul 28 06:13 PM
Weidemanis Joakim	Executive Vice President	Jul 27	Sale	196.00	19,834	3,887,464	92,714	Jul 28 06:16 PM
COMAS DANIEL L	EVP	Jul 27	Sale	200.87	8,000	1,606,937	96,933	Jul 28 06:12 PM
COMAS DANIEL L	EVP	Jul 24	Option Exercise	59.78	88,978	5,318,953	163,911	Jul 28 06:12 PM
Joyce Thomas Patrick JR	President and CEO	Jul 24	Option Exercise	65.90	181,394	11,953,088	302,851	Jul 28 06:13 PM
SCHWIETERS JOHN T	Director	Jul 24	Option Exercise	28.98	11,014	319,186	25,394	Jul 28 06:15 PM
SCHWIETERS JOHN T	Director	Jul 24	Sale	193.95	6,014	1,166,403	19,380	Jul 28 06:15 PM
Joyce Thomas Patrick JR	President and CEO	Jul 24	Sale	193.98	181,394	35,186,837	203,513	Jul 28 06:13 PM
COMAS DANIEL L	EVP	Jul 24	Sale	195.27	3,054	596,391	0	Jul 28 06:12 PM
COMAS DANIEL L	EVP	Jul 24	Sale	193.97	88,978	17,258,652	104,933	Jul 28 06:12 PM
RALES MITCHELL P	Chairman of Exec. Committee	May 29	Buy	164.69	141,420	23,291,085	2,377,874	Jun 02 04:30 PM
LOHR WALTER G	Director	May 28	Option Exercise	28.98	11,014	319,186	22,392	May 29 05:11 PM
Blair Rainer	Executive Vice President	May 28	Sale	165.96	3,330	552,637	36,256	May 29 05:13 PM
LOHR WALTER G	Director	May 28	Sale	165.61	11,014	1,824,029	11,378	May 29 05:11 PM
COMAS DANIEL L	EVP	May 18	Sale	165.68	18,259	3,025,078	104,933	May 19 05:11 PM
RALES MITCHELL P	Chairman of Exec. Committee	May 12	Buy	163.00	1,226	199,838	2,256	May 12 04:12 PM
Raskas Daniel	SVP-Corporate Development	May 08	Option Exercise	37.51	29,011	1,088,203	48,734	May 12 05:30 PM
LUTZ ROBERT S	SVP-Chief Accounting Officer	May 08	Option Exercise	40.45	28,389	1,148,335	47,339	May 12 05:29 PM
Raskas Daniel	SVP-Corporate Development	May 08	Sale	164.09	37,082	6,084,929	19,723	May 12 05:30 PM
LUTZ ROBERT S	SVP-Chief Accounting Officer	May 08	Sale	161.68	33,892	5,479,696	18,950	May 12 05:29 PM
Lalor Angela S	SVP, Human Resources	May 08	Sale	163.03	8,031	1,309,270	35,910	May 12 05:27 PM
Ellis Brian W	SVP, GC & CCO	May 08	Sale	163.40	2,870	468,969	24,837	May 12 05:27 PM
SPOON ALAN G	Director	Mar 20	Option Exercise	33.18	19,912	660,742	111,293	Mar 23 05:19 PM
DANIEL WILLIAM K	EVP	Mar 04	Sale	147.54	0	65	94,384	Mar 06 05:10 PM
King William	SVP, Strategic Development	Feb 20	Option Exercise	44.03	23,808	1,048,234	34,865	Feb 24 06:21 PM
King William	SVP, Strategic Development	Feb 20	Sale	160.23	26,370	4,225,191	19,865	Feb 24 06:21 PM
EHRLICH DONALD J	Director	Feb 10	Option Exercise	28.98	6,014	174,286	129,217	Feb 11 05:51 PM
DANIEL WILLIAM K	EVP	Feb 10	Sale	163.23	20,733	3,384,316	88,986	Feb 12 05:13 PM
EHRLICH DONALD J	Director	Feb 10	Sale	163.13	6,014	981,034	123,203	Feb 11 05:51 PM
Joyce Thomas Patrick JR	President and CEO	Feb 07	Sale	162.03	20,492	3,320,257	157,694	Feb 11 05:50 PM
COMAS DANIEL L	EVP	Feb 04	Option Exercise	56.70	50,000	2,835,000	156,479	Feb 05 08:43 PM
COMAS DANIEL L	EVP	Feb 04	Sale	163.26	50,000	8,162,950	106,479	Feb 05 08:43 PM
COMAS DANIEL L	EVP	Feb 03	Option Exercise	56.70	3,100	175,770	108,579	Feb 04 08:46 PM
Lalor Angela S	SVP, Human Resources	Feb 03	Option Exercise	46.13	18,267	842,657	56,782	Feb 04 08:51 PM
McGrew Matthew	EVP & Chief Financial Officer	Feb 03	Option Exercise	40.45	7,894	319,312	29,214	Feb 04 08:53 PM
McGrew Matthew	EVP & Chief Financial Officer	Feb 03	Sale	161.98	11,304	1,831,030	21,320	Feb 04 08:53 PM
Lalor Angela S	SVP, Human Resources	Feb 03	Sale	161.49	18,267	2,949,846	38,515	Feb 04 08:51 PM
COMAS DANIEL L	EVP	Feb 03	Sale	161.34	3,100	500,167	106,479	Feb 04 08:46 PM
Blair Rainer	Executive Vice President	Jan 31	Option Exercise	57.10	33,467	1,910,813	49,752	Feb 04 08:45 PM
COMAS DANIEL L	EVP	Jan 31	Option Exercise	57.90	79,364	4,595,176	188,583	Feb 04 08:46 PM
Joyce Thomas Patrick JR	President and CEO	Jan 31	Option Exercise	62.82	132,474	8,321,445	277,663	Feb 04 08:49 PM
Joyce Thomas Patrick JR	President and CEO	Jan 31	Sale	162.51	132,474	21,527,890	195,608	Feb 04 08:49 PM
COMAS DANIEL L	EVP	Jan 31	Sale	161.50	79,364	12,817,492	115,442	Feb 04 08:46 PM
Blair Rainer	Executive Vice President	Jan 31	Sale	163.50	36,440	5,957,881	27,313	Feb 04 08:45 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience